ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Uncovering Hidden Mechanisms of Different Prescriptions Treatment for Osteoporosis via Novel Bioinformatics Model and Experiment Validation

Liu, Yujie; Liu, Qinwen; Yin, Chuanhui; Li, Yi; Wu, Jie; Chen, Quanlin; Yu, Hailang; Lu, Aiping*; Guan, Daogang*南方医科大学
Frontiers in Cell and Developmental Biology2022-2-8DOI: 10.3389/fcell.2022.831894
4被引7阅读
引用收藏
分享

摘要

Osteoporosis (OP) is a systemic disease susceptible to fracture due to the decline of bone mineral density and bone mass, the destruction of bone tissue microstructure, and increased bone fragility. At present, the treatments of OP mainly include bisphosphonates, hormone therapy, and RANKL antibody therapy. However, these treatments have observable side effects and cannot fundamentally improve bone metabolism. Currently, the prescription of herbal medicine and their derived proprietary Chinese medicines are playing increasingly important roles in the treatment of OP due to their significant curative effects and few side effects. Among these prescriptions, Gushukang Granules (GSK), Xianling Gubao Capsules (XLGB), and Er-xian Decoction (EXD) are widely employed at the clinic on therapy of OP, which also is in line with the compatibility principle of "different treatments for the same disease" in herbal medicine. However, at present, the functional interpretation of "different treatments for the same disease" in herbal medicine still lacks systematic quantitative research, especially on the detection of key component groups and mechanisms. To solve this problem, we designed a new bioinformatics model based on random walk, optimized programming, and information gain to analyze the components and targets to figure out the Functional Response Motifs (FRMs) of different prescriptions for the therapy of OP. The distribution of high relevance score, the number of reported evidence, and coverage of enriched pathways were performed to verify the precision and reliability of FRMs. At the same time, the information gain and target influence of each component was calculated, and the key component groups in all FRMs of each prescription were screened to speculate the potential action mode of different prescriptions on the same disease. Results show that the relevance score and the number of reported evidence of high reliable genes in FRMs were higher than those of the pathogenic genes of OP. Furthermore, the gene enrichment pathways in FRMs could cover 79.6, 81, and 79.5% of the gene enrichment pathways in the component-target (C-T) network. Functional pathway enrichment analysis showed that GSK, XLGB, and EXD all treat OP through osteoclast differentiation (hsa04380), calcium signaling pathway (hsa04020), MAPK signaling pathway (hsa04010), and PI3K-Akt signaling pathway (hsa04151). Combined with experiments, the key component groups and the mechanism of "different treatments for the same disease" in the three prescriptions and proprietary Chinese medicines were verified. This study provides methodological references for the optimization and mechanism speculation of Chinese medicine prescriptions and proprietary Chinese medicines.

学科与关键词

关键词
osteoporosisGushukang GranulesXianling Gubao CapsulesEr-xian Decoctionherbal medicinefunctional response motif
相关
加载中…
  • Analysis of Molecular Mechanism of Erxian Decoction in Treating Osteoporosis Based on Formula Optimization Model
    Yang, Lang; Fan, Liuyi; Wang, Kexin; Chen, Yupeng; Liang, Lan; Qin, Xuemei; Lu, Aiping; Cao, Peng; Yu, Bin*; Guan, Daogang*; Peng, Junxiang*Oxidative Medicine and Cellular Longevity, 2021, 2021: 6641838.被引 27
  • Network Pharmacological Study on Mechanism of the Therapeutic Effect of Modified Duhuo Jisheng Decoction in Osteoporosis
    Huang, Xudong; Zhou, Zhou; Zheng, Yingyi; Fan, Guoshuai; Ni, Baihe; Liu, Meichen; Zhao, Minghua; Zeng, Lingfeng*; Wang, Weiguo*Frontiers in Endocrinology, 2022, 13: 860649.被引 2
  • Bioinformatics analysis combined with molecular dynamics simulation validation to elucidate the potential molecular mechanisms of Jianshen Decoction for treatment of osteoporotic fracture
    Liu, Weinian; Chen, Weijian; Hu, Mengting; Wang, Guangwei; Hu, Yuanhao; He, Qi; Xu, Yidong; Tan, Jun; Wang, Haibin; Huo, Liwei*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(16).
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2022-02-08
卷期
第 10 卷
页码
831894
DOI
10.3389/fcell.2022.831894
期刊等级
3区
成果收录
SCIE
资助标注
Startup fund from Southern Medical University [G619280010]; Natural Science Foundation Council of China [32070676, 31501080]; National Key R&D Program of China [2018YFC1705205]; Natural Science Foundation of Guangdong Province [2021A1515010737]; Hong Kong Baptist University Strategic Development Fund [SDF13-1209-P01, SDF15-0324-P02, SDF19-0402-P02]; Hong Kong Baptist University Interdisciplinary Research Matching Scheme [RC/IRCs/17-18/04]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund [2020B1212030006]

作者

  • L

    Liu, Yujie (第一作者)

    southern med univ

  • L

    Liu, Qinwen

    southern med univ

查看全部 9 位作者收起作者
  • Y

    Yin, Chuanhui

    southern med univ

  • L

    Li, Yi

    southern med univ

  • W

    Wu, Jie

    southern med univ

  • C

    Chen, Quanlin

    southern med univ

  • Y

    Yu, Hailang

    southern med univ

  • L

    Lu, Aiping (通讯)

    hong kong baptist univ

  • G

    Guan, Daogang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417